These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1804493)

  • 21. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219.
    Smith LJ; Glass M; Minkwitz MC
    Clin Pharmacol Ther; 1993 Oct; 54(4):430-6. PubMed ID: 8222486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of SK&F 104353, a leukotriene receptor antagonist, on the bronchial responses to histamine in subjects with asthma: a comparative study with terfenadine.
    Dinh Xuan AT; Regnard J; Similowski T; Rey J; Marsac J; Lockhart A
    J Allergy Clin Immunol; 1990 May; 85(5):865-71. PubMed ID: 1970584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics.
    Van Schoor J; Joos GF; Chasson BL; Brouard RJ; Pauwels RA
    Eur Respir J; 1998 Jul; 12(1):17-23. PubMed ID: 9701408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.
    Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE
    J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects.
    Fuller RW; Black PN; Dollery CT
    J Allergy Clin Immunol; 1989 May; 83(5):939-44. PubMed ID: 2715552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics.
    Joos GF; Van Schoor J; Kips JC; Pauwels RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1781-4. PubMed ID: 8665034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms.
    Manning PJ; Watson RM; O'Byrne PM
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):950-4. PubMed ID: 8214949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosolized acetaldehyde induces histamine-mediated bronchoconstriction in asthmatics.
    Myou S; Fujimura M; Nishi K; Ohka T; Matsuda T
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):940-3. PubMed ID: 7692778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
    Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
    Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responsiveness to leukotriene D4 in normal and asthmatic subjects.
    Diamant Z; Timmers MC; van der Veen H; Booms P; Sont JK; Sterk PJ
    Eur Respir J; 1994 Mar; 7(3):459-66. PubMed ID: 8013602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.
    Britton JR; Hanley SP; Tattersfield AE
    J Allergy Clin Immunol; 1987 May; 79(5):811-6. PubMed ID: 3571772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
    Smith EF; Slivjak MJ; Eckardt RD; Newton JF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.
    O'Shaughnessy KM; Taylor IK; O'Connor B; O'Connell F; Thomson H; Dollery CT
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1431-5. PubMed ID: 8389105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078.
    Yamamoto H; Nagata M; Kuramitsu K; Tabe K; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y
    Am J Respir Crit Care Med; 1994 Jul; 150(1):254-7. PubMed ID: 8025759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of platelet-activating factor-induced bronchoconstriction by the leukotriene D4 receptor antagonist ICI 204,219.
    Kidney JC; Ridge SM; Chung KF; Barnes PJ
    Am Rev Respir Dis; 1993 Jan; 147(1):215-7. PubMed ID: 8420421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of inhaled budesonide on the maximal degree of airway narrowing to leukotriene D4 and methacholine in normal subjects in vivo.
    Bel EH; van der Veen H; Dijkman JH; Sterk PJ
    Am Rev Respir Dis; 1989 Feb; 139(2):427-31. PubMed ID: 2643902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacological profile of SK&F 104353-Z2, a potent, selective inhaled antagonist of cysteinyl leukotrienes, in normal man.
    Evans JM; Piper PJ; Costello JF
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():469-72. PubMed ID: 1825584
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodynamic effects of leukotriene (LT) D4 and a LTD4 receptor antagonist in the pig.
    Zellner JL; Cook JA; Reines DH; Wise WC; Smith EF; Kessler LD; Halushka PV
    Eicosanoids; 1990; 3(4):219-24. PubMed ID: 1963540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
    Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
    N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal and prevention of airway response to antigen challenge by the inhaled leukotriene D4 antagonist (L-648,051) in patients with atopic asthma.
    Rasmussen JB; Eriksson LO; Andersson KE
    Allergy; 1991 May; 46(4):266-73. PubMed ID: 1897688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.